chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At 4 weeks old she began to have breathing problems. We took her to the ER and she was diagnosed with croup. She was given breathing treatments and oral steroids. Since that time she has been diagnosed with asthma and continues to suffer from respiratory illnesses.
I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May). On 31-May-2021, PRODUCT DOSE OMISSION ISSUE (I had my first shot on May 3rd 2021. I haven't had the second one yet. It was due 31st May) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided.  Treatment information was not provided.
Body aches, fatigue, stuffy head feeling but no congestion. I took Aleve and Advil for the aches.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 09-APR-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) lot # k025766, expiry date 08-JUN-2015. This is one of the several reports received from the same reporter. Additional information has been requested.
A non-serious, spontaneous report of FLUMIST given by mistake to an 18 month-old infant girl was received from a consumer.  There was no adverse event associated with this medication error; therefore treatment and reporter/sponsor causality assessments are not applicable and the event is considered resolved.  This case is submitted in accordance with MedImmune's post-marketing commitment on accelerated reporting for the newly indicated population of 2 years to 59 months of age for FLUMIST.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 29-AUG-2017 the patient was vaccinated with VAQTA lot # N012324 for prophylaxis. Other suspect therapies included ROTATEQ, PEDVAXHIB and M-M-R II (rHA). Concomitant therapies included sterile diluent. On 29-AUG-2017, 1 day after onset of therapy the patient experienced incorrect product storage. On an unknown date the patient experienced no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage to be not related to M-M-R II, ROTATEQ, PEDVAXHIB and VAQTA. The reporter considered no adverse event to be not related to ROTATEQ, M-M-R II, PEDVAXHIB and VAQTA. Sender's Comments: US-009507513-1708USA012838: US-009507513-1708USA013542: US-009507513-1708USA013545: US-009507513-1708USA013546: US-009507513-1708USA013547: US-009507513-1708USA013548: US-009507513-1708USA013549: US-009507513-1708USA013550: US-009507513-1708USA013551: US-009507513-1708USA013552: US-009507513-1708USA013538: US-009507513-1708USA013537: US-009507513-1708USA013539: US-009507513-1708USA013540: US-009507513-1708USA013541: US-009507513-1708USA013544.
COVID-19 pneumonia Hypoxia 79 year old woman with COPD on chronic home O2 at 1L NC presented to the ER with worsening cough and dyspnea.  Per daughter, it started Monday this week.  It progressed as the week went on .  There was no productive sputum.  The patient was found with COVID-19 infection, but the CXR showed possible fluid overload.  Pt recovered from COVID in January (she was flown and spent some time admitted for her COVID - 20d at Facility).  Her current oxygen requirement was around 2L NC.  She usually uses 1L NC at home.
Patient was administered an expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine). On 23-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.  No treatment information was provided.
Debilitating migraine 2 days after, which continued for 8 days. I then got another one two weeks later for 7 days. It's continued in this pattern. Today is a migraine day. They are now every 2 weeks for 10 days. I have 10 out of 30 good days since my booster shot.
Large erythema at the site of the injection. it is itchy and hot. She denies any fever, chills, SOB.
I few days after receiving my second dose of vaccine, I had to end up going to my dr office, because I felt numbed and started experiencing minor aches, pain and loss of taste. My provider stated that its a strong possibility that the cause of these events was due to the vaccine. I received an injection while I was at the provider's office for Hydrocortisone and he also prescribed nerve pain medicine. The next morning following my immediate appointment with my provider, I started feeling better. Maybe a week after that my taste returned. Now I have fully recovered.
itching all over his body; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching all over his body) and HEADACHE (Headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 026B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Dialysis.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching all over his body) and HEADACHE (Headache). At the time of the report, PRURITUS (itching all over his body) and HEADACHE (Headache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported.   This case was linked to MOD-2021-081603 (Patient Link).
I had typical fly symptoms including a fever, aches and pains, congestion, difficulty breathing, coughing that almost caused convulsions. I thought it was a normal flu, but as the symptoms progressively got worse, I decided to take an at-home COVID-19 test the next day. I tested positive for COVID-19 on 03/03/2023. The doctor offered me Paxlovid so I retrieved my prescription and used my asthma inhaler as well for recovery. After I finished the treatment, I still had some residual symptoms remaining. It wasn't as bad, but I knew the symptoms reappeared. It took almost a month before I feel I made a full recovery.  The month after recovery, I had a tickle in my chest after doing anything that required a little more lung function including exercise, laughing, or a light cough. Eventually that went away as well.
Rash all over leg on 8/18/10 received varicella vaccine 08/13/2010.
Stated he became very "tired, hands felt tingly, heart rate dropped to 40's, felt light headed". Went to the emergency department, blood pressure elevated. They did labs, EKG, and gave IV fluids. He was later discharged from the emergency department. Spoke with him by phone 10/13/17 and he is feeling better, no continuing symptoms.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Nov2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 68 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: developed rebound symptoms and tested positive for Covid-19 antigen 10 days after symptom resolution and negative test on day 6 following treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
fever, uncontrollable shivering, bad headache, all over body aches (hurts to move), lightheaded when standing, lethargy
This spontaneous report as received from a registered nurse regarding unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with GARDASIL 9 (Lot # L020015 and expiry: 16-AUG-2017), route, strength and dose were not reported, which was improperly stored at 23 degrees Fahrenheit for 11 hours. The patients experienced no adverse events. There was no prior temperature excursions and nurse called because of data logger. This is one of the several reports from the same reporter. Additional information has been requested.
rash developed on face, neck and LEFT arm within 5 minutes of administration, Benadryl given and rash improved within about 10 minutes
Presented with petechiae. Platelet count 39,000. Admitted for ITP, received IVIG.
no adverse effect reported; patient was administered an improperly stored dose of VARIVAX; This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's concurrent condition and medical history was unknown. Concomitant therapy included sterile diluent. On 08-JUN-2019, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # S002874 with expiry date 29-JAN-2021 (strength, dose, frequency, route of administration unspecified) for prophylaxis (product storage error). The diluent used to reconstitute the vaccine was properly stored. On an unknown date, the vaccine was exposed to 7.46 Fahrenheit temperature for 20 minutes. No previous temperature excursion was reported. Digital data logger was involved. No adverse effect (no adverse event) reported. The outcome of the event was unknown.
Patient received influenza vaccine on 10/5/07.  Patient also receiving chemotherapy from different physician for bladder cancer.  Patient with a fever of 103 degrees F on 10/8/07.  Advised to seek attention with his oncologist or at an acute care facility.
Shortness of breath, pain in chest, heart rate elevated for 2-3 weeks. 60-65 normal up to 92 after vaccine.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 23-OCT-2014, the patient was vaccinated with ZOSTAVAX (batch/lot#, expiration date, dose and route were not provided). On approximately 02-NOV-2014 (Reported as 2 days ago), the patient experienced blisters on the opposite shoulder from injection site. The outcome of blisters on the opposite shoulder from injection site was unknown. The relatedness between the event and therapy with ZOSTAVAX was not reported. Additional information has been requested.
Feeling tingly just not right; This is a spontaneous report from a contactable nurse. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an intramuscular route of administration in the left arm on 22Apr2021 at 11:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included diphenhydramine hydrochloride (BENADRYL) from an unknown date for an unknown indication and unknown if ongoing. On 22Apr2021 at 12:00, the patient complained of (c/o) feeling tingly just not right. The patient had no shortness of breath (sob) or any other allergic reaction. The symptoms resolved without (w/o) intervention. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of event  feeling tingly just not right was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: Patient was given vaccination and after about 5 minutes, he notified the pharmacist and technician that he had passed out. He was laid on a bench with his feet elevated then monitored for an additional 30 minutes. He was driven home by his parents who had accompanied him and was checked up again a few hours later with a phone call. He stated he was feeling fine.
Reports of pain and soreness on the right side of her body mostly in her right arm and joints starting on 12/10/2021 through current.  She continues to have full rang of motion and strength to all extremities.  Headache reported.   No localized reaction at injection site.
11 hours after vaccination, sudden shaking chills for a half hour, followed by significant malaise for a day (spent mostly in bed), gradually improving over the next few days, but with mild residual fatigue which has still not resolved completely. No treatment other than ibuprofen, as I assumed it was an immune reaction and would resolve on its own.
approximately 1 week to the day after receiving vaccination I noticed red, swollen, itchy, painful, warm to the touch circle around the injection site.  The next day the size had doubled and all symptoms increased (redness, tenderness, hard under skin, swelling etc.) so I went to the Urgent Care clinic and they diagnosed it as Cellulitis.
Pt with urticarial rash to face progressed to body in 2 days given Pred taper, ZYRTEC and ZANTAC.
On January 16, 2021 I started to have axillary swelling and tenderness. Now on January 27, 2021, that discomfort and tenderness is still present. I have also had a large raised, red, hot, itchy local reaction at the vaccination site that has come and gone throughout these past two weeks. Today it is at its worst.
UNSURE IF ENERGIX B or RECOMBIVAX and UNSURE OF LOT, ROUTE, and DOSE - this shot was supposed to be a booster, patient would have had the series as an infant or child based on state requirements.
Pt called 1/13/11 to report he had almost immediate pain, redness and swelling at injection site radiating under the right arm (axilla). Another pt. in our clinic reported similar reaction to same med, same lot #.
Patient presented for her flu shot at a mobile vaccination clinic. Upon billing the claim, we discovered patient had already received her flu vaccine for the 2022-2023 season. I spoke with patient on 2/1/2023 and patient reports no side effects or issues.
Severe vertigo  that had an onset of 4 days after my second dose of vaccine and is still ongoing so at this point has lasted 4 days. I understand it?s not a life threatening thing but has been very distressing and scary to me. Has been interfering with my ability to work and do regular life activities such as driving, and walking without fear of falling. I hope it goes away.
Influenza vaccine administered on 10/04/10 at approx. 08:20AM. Patient reports that approx 4 hours after receiving influenza vaccine he was driving with sunglasses on and it got very bright even with sunglasses on and he felt a lump in his throat. Denied shortness of breath or any breathing problems. States when he woke up the next day all symptoms were gone & he felt fine. Patient did not seek any medical help.
a ROT ATEQ vaccine which had been improperly stored was administered to a patient; This spontaneous report was received from a medical assistant referring to a patient of unknown gender and age. The patient's medical history, concurrent conditions, previous drug reactions or allergies and concomitant therapies were unknown.  On 28-DEC-2020, the patient was vaccinated with a improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (dose, strength and route were not reported, lot # 1684157 has been verified as valid, expiration date 26-JUN-2021) for prophylaxis (product storage error). The excursion was supported as below 36 Fahrenheit (32.1 F) for 5 hours and 40 minutes. There were no previous temperature excursions. The vaccines were back in range at the reporting time. The digital data logger was involved.
shingles; Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication.   In 2017, the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (dose, route, lot# and expiration date were unknown) for the long-term prevention of shingles and/or zoster-related conditions(for prophylaxis). Subsequent to patient's zoster vaccine live(ZOSTAVAX) inoculation, patient was treated for shingles.  As a direct and proximate result of patient's use of the zoster vaccine live(ZOSTAVAX) vaccine, patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.
the day following the vaccine, pt was nauseous and headache. patient states that starting the 29th, she had a rash that spread down her entire body and she went to the ER. Since the vaccine her arm has remained sore
1st Vaccine 1/9/21; 2nd Vaccine 1/28/21; symptomatic 2/18/21 with sore throat, mild SOA, and diarrhea ; seen at Facility 2/19/21 for symptoms and tested COVID + ;  >14 days post 2nd vaccine
administered Infanrix instead of Boostrix; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a female patient who received DTPa (Infanrix) (batch number 7KM94, expiry date 10th June 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date unknown batch number.).   On 30th June 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 30-JUN-2022 Reporter's Comment:  The nurse practitioner stated that patient that a 29 year old patient was inadvertently administered the Infanrix vaccine instead of Boostrix at the time of reporting. Additional supportive information The patient received Infanrix vaccine instead of Boostrix, which led to wrong vaccine administered.
1: Very high fever, starting 15 hours post-injection, peaking at 105.2, resolved within 14 hours from onset.  2: Extreme eye irritation and redness in right eye, which had contact lens in. Onset 18 hours post-injection, resolved approx. 36h later. Removed lens immediately after onset.  3: Extreme eye irritation and redness in left eye, which *did not* have contact lens in. Onset 26h post-injection, resolved approx. 24h later.  Note: No reaction to 1st vaccine dose at all, not even injection site soreness. COVID-19 (PCR positive) 5 months prior to 1st dose; sympomatic but mild: low grade fever resolving within 4 hours of onset, anosmia, nasal congestion, moderate headache.  No professional treatment sought, treated symptoms with ibuprofen, resolved within 6 days.  2/3 likely coincidental, but due to time proximity to vaccine I wanted to report it in case a pattern emerged.
Patient is legally blind from diabetic retinopathy and after the Moderna Covid 19 booster he experienced a severe decline in his vision.
Date and time adverse event started: 3-16-21 just after the vaccine, was told to wait in her car for the observation time, states she saw an EMS at the site and addressed her issued to him.  trembling feeling, legs felt like jello and unable to walk (while the 15min obs time at the vaccine site), and "pressure/tightness" to head.  the EMS asked if she had ate and reported her missing a meal cold be the issue. reported he checked her oxygen saturation reading at 99%. What happened as a result of the adverse event? (doctor visit, ED or urgent care visit, hospitalization, life threatening illness, disability/permanent damage, death, none of these):  report she has an appointment scheduled with her PCP on Monday.
This spontaneous report was received from a licensed practical nurse concerning an unspecified number of patients (ages and genders not specified) who reported that one dose of VARIVAX (Merck) and 10 doses of PROQUAD (Merck) that were improperly stored were administerd to an unspecified number of patients. No adverse effects were reported. Additional information has been requested.
Having numbness in right arm from fingertips to shoulder. Also numbness in right ear and cheek. Patient was advised to contact his PCP or go to the ER.
Patient had gotten a J and J vaccine in March/April from another facility  and then got a 1st dose Pfizer from Pharmacy on 8/6/21